Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002027733 | SCV002310393 | likely benign | Noonan syndrome 9 | 2025-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004044725 | SCV005025049 | uncertain significance | Cardiovascular phenotype | 2024-02-03 | criteria provided, single submitter | clinical testing | The p.L831R variant (also known as c.2492T>G), located in coding exon 15 of the SOS2 gene, results from a T to G substitution at nucleotide position 2492. The leucine at codon 831 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. |